Actos Bladder Cancer Warning

The Food and Drug Administration (FDA) issued a warning in June 2011 that the use of the diabetes drug Actos may increase a patient’s risk of developing bladder cancer. The Actos warning was based on results of a 10-year study reporting that patients treated with Actos for more than one year or who were prescribed high doses of the drug were at a higher risk of developing bladder cancer.

The FDA warning letter stated that doctors should not prescribe Actos to patients who currently have bladder cancer. The agency also advised doctors to use caution when prescribing the drug to individuals who were previously treated for bladder cancer and to weigh the benefits of Actos as a diabetes treatment against the risks of potential cancer recurrence.

The FDA Actos warning advised patients to speak with a doctor if they develop any symptoms of bladder cancer, including blood or a red color in the urine, pain while urinating, lower back pain or abdominal pain.

If you or a loved one were diagnosed with bladder cancer after using Actos, you may qualify to file a lawsuit. For a free legal consultation, contact the bladder cancer lawyers at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.